Chemours Historical Balance Sheet
| CC Stock | USD 16.83 0.96 5.40% |
Trend analysis of Chemours Co balance sheet accounts such as Total Assets of 7.5 B or Other Current Liabilities of 1.5 B provides information on Chemours' total assets, liabilities, and equity, which is the actual value of Chemours to its prevalent stockholders. By breaking down trends over time using Chemours balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Chemours latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chemours is a good buy for the upcoming year.
Chemours Inventory |
|
Chemours |
About Chemours Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Chemours at a specified time, usually calculated after every quarter, six months, or one year. Chemours Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Chemours and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Chemours currently owns. An asset can also be divided into two categories, current and non-current.
Chemours Balance Sheet Chart
Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of Chemours assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Chemours books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Chemours balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Chemours Co are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Chemours' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 1.1 B, whereas Total Assets are forecasted to decline to about 7.5 B.
| 2022 | 2023 | 2024 | 2025 (projected) | Other Current Liabilities | 475M | 1.2B | 1.4B | 1.5B | Total Assets | 7.6B | 8.3B | 9.5B | 7.5B |
Chemours balance sheet Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours balance sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Common Stock Shares Outstanding | 166.3M | 168.7M | 158.3M | 148.9M | 134.0M | 140.1M | |
| Total Assets | 7.1B | 7.6B | 7.6B | 8.3B | 9.5B | 7.5B | |
| Other Current Liab | 449M | 545M | 475M | 1.2B | 1.4B | 1.5B | |
| Total Current Liabilities | 1.4B | 1.9B | 1.9B | 2.5B | 2.9B | 1.8B | |
| Total Stockholder Equity | 813M | 1.1B | 1.1B | 737M | 663.3M | 1.1B | |
| Other Liab | 751M | 626M | 707M | 854M | 982.1M | 711.9M | |
| Property Plant And Equipment Net | 3.7B | 3.4B | 3.4B | 3.5B | 4.0B | 3.6B | |
| Accounts Payable | 820M | 1.2B | 1.2B | 1.1B | 1.3B | 1.1B | |
| Non Current Assets Total | 4.4B | 4.2B | 4.4B | 4.4B | 5.1B | 4.4B | |
| Other Assets | 292M | 405M | 547M | 725M | 833.8M | 424.1M | |
| Long Term Debt | 4.0B | 3.7B | 3.6B | 4.0B | 4.6B | 3.2B | |
| Net Receivables | 511M | 720M | 626M | 610M | 549M | 602.4M | |
| Liabilities And Stockholders Equity | 7.1B | 7.6B | 7.6B | 8.3B | 9.5B | 7.5B | |
| Non Current Liabilities Total | 4.8B | 4.6B | 4.6B | 5.0B | 5.8B | 4.1B | |
| Inventory | 939M | 1.1B | 1.4B | 1.4B | 1.6B | 1.2B | |
| Other Current Assets | 156M | 150M | 82M | 670M | 770.5M | 809.0M | |
| Other Stockholder Equity | (182M) | (303M) | (722M) | (773M) | (695.7M) | (660.9M) | |
| Total Liab | 6.3B | 6.5B | 6.5B | 7.5B | 8.6B | 6.0B | |
| Property Plant And Equipment Gross | 3.7B | 9.2B | 9.4B | 9.6B | 11.1B | 11.6B | |
| Total Current Assets | 2.6B | 3.3B | 3.2B | 3.8B | 4.4B | 3.0B | |
| Accumulated Other Comprehensive Income | (310M) | (364M) | (343M) | (274M) | (246.6M) | (258.9M) | |
| Short Term Debt | 78M | 84M | 141M | 106M | 95.4M | 97.8M | |
| Intangible Assets | 21M | 14M | 6M | 3M | 2.7M | 2.6M | |
| Property Plant Equipment | 3.9B | 3.5B | 3.4B | 3.2B | 3.6B | 3.5B | |
| Net Tangible Assets | 515M | 646M | 973M | 992M | 892.8M | 710.5M | |
| Retained Earnings | 1.3B | 1.7B | 2.2B | 1.8B | 2.0B | 1.1B | |
| Cash | 1.1B | 1.5B | 1.1B | 1.2B | 1.4B | 1.1B | |
| Deferred Long Term Liab | 148M | 36M | 49M | 61M | 54.9M | 96.1M | |
| Long Term Investments | 167M | 169M | 175M | 158M | 181.7M | 171.6M | |
| Short Long Term Debt | 134M | 21M | 25M | 51M | 58.7M | 41.5M | |
| Short Long Term Debt Total | 4.3B | 3.9B | 3.8B | 4.3B | 4.9B | 4.4B | |
| Net Debt | 3.2B | 2.5B | 2.7B | 3.1B | 2.8B | 2.4B | |
| Cash And Short Term Investments | 1.1B | 1.5B | 1.1B | 1.2B | 1.4B | 1.2B | |
| Retained Earnings Total Equity | 1.2B | 1.3B | 1.7B | 2.2B | 2.5B | 2.6B | |
| Long Term Debt Total | 4.0B | 4.0B | 3.7B | 3.6B | 3.2B | 3.1B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.5 | Revenue Per Share | Quarterly Revenue Growth 0.009 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.